MX2013010019A - Metodo para aislamiento de osteopontina utilizando alimentos concentrados. - Google Patents
Metodo para aislamiento de osteopontina utilizando alimentos concentrados.Info
- Publication number
- MX2013010019A MX2013010019A MX2013010019A MX2013010019A MX2013010019A MX 2013010019 A MX2013010019 A MX 2013010019A MX 2013010019 A MX2013010019 A MX 2013010019A MX 2013010019 A MX2013010019 A MX 2013010019A MX 2013010019 A MX2013010019 A MX 2013010019A
- Authority
- MX
- Mexico
- Prior art keywords
- osteopontin
- feeds
- concentrated feeds
- isolating osteopontin
- isolating
- Prior art date
Links
- 102000004264 Osteopontin Human genes 0.000 title abstract 3
- 108010081689 Osteopontin Proteins 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 239000008267 milk Substances 0.000 abstract 2
- 210000004080 milk Anatomy 0.000 abstract 2
- 235000013336 milk Nutrition 0.000 abstract 2
- 238000002955 isolation Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Peptides Or Proteins (AREA)
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161448775P | 2011-03-03 | 2011-03-03 | |
| EP11156826 | 2011-03-03 | ||
| PCT/EP2012/053749 WO2012117120A1 (en) | 2011-03-03 | 2012-03-05 | Method for isolating osteopontin using concentrated feeds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2013010019A true MX2013010019A (es) | 2014-05-20 |
Family
ID=44202290
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013010019A MX2013010019A (es) | 2011-03-03 | 2012-03-05 | Metodo para aislamiento de osteopontina utilizando alimentos concentrados. |
| MX2013010017A MX2013010017A (es) | 2011-03-03 | 2012-03-05 | Metodo para aislamiento de osteopontina utilizando alimentos que contienen especies de cmp o caseina. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013010017A MX2013010017A (es) | 2011-03-03 | 2012-03-05 | Metodo para aislamiento de osteopontina utilizando alimentos que contienen especies de cmp o caseina. |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US9181325B2 (enExample) |
| EP (2) | EP2681231B1 (enExample) |
| JP (2) | JP6012053B2 (enExample) |
| KR (2) | KR101940829B1 (enExample) |
| CN (3) | CN103476787B (enExample) |
| AR (2) | AR088719A1 (enExample) |
| AU (2) | AU2012222312B2 (enExample) |
| BR (2) | BR112013022252B1 (enExample) |
| CA (2) | CA2828746C (enExample) |
| DK (2) | DK2681231T3 (enExample) |
| EA (2) | EA023615B1 (enExample) |
| ES (2) | ES2565380T3 (enExample) |
| MX (2) | MX2013010019A (enExample) |
| PL (2) | PL2681231T3 (enExample) |
| WO (2) | WO2012117120A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107257152B (zh) * | 2011-04-28 | 2021-04-09 | 佐尔循环公司 | 用于更新数据、操作参数和/或软件的系统 |
| EA201491691A1 (ru) | 2012-03-28 | 2015-04-30 | Арла Фудз Амба | Агрегаты наночастиц, содержащие остеопонтин и кальций- и/или стронцийсодержащие частицы |
| NZ715430A (en) * | 2013-07-05 | 2022-01-28 | Arla Foods Amba | Mammalian milk osteopontin for enhancing immune responsiveness |
| US9661868B2 (en) * | 2013-07-16 | 2017-05-30 | Mead Johnson Nutrition Company | Expanded bed adsorption methods for isolation of basic milk proteins including lactoferrin |
| KR200482960Y1 (ko) | 2016-04-07 | 2017-03-21 | 오숙희 | 고주파 얼굴 축소 시술기 |
| CN109906040A (zh) * | 2016-07-06 | 2019-06-18 | 积木营养品有限公司 | 营养配方食品 |
| US12109284B2 (en) | 2016-11-08 | 2024-10-08 | Dentherapy Ltd | Compositions comprising fluoride and calcium and method for preparing them |
| US20200404946A1 (en) * | 2017-12-22 | 2020-12-31 | Societe Des Produits Nestle Nestle S.A. | Extracts and their use |
| CN109613140B (zh) * | 2019-01-07 | 2021-10-08 | 雅士利国际集团有限公司 | 食品中酪蛋白磷酸肽的检测方法 |
| CA3182755A1 (en) | 2020-06-15 | 2021-12-23 | James W. McGrath Jr. | Nutritional formula |
| GB202010987D0 (en) | 2020-07-16 | 2020-09-02 | Dentherapy Ltd | Oral care compositions and methods |
| CN117377391A (zh) * | 2021-04-19 | 2024-01-09 | 雀巢产品有限公司 | 乳蛋白质级分作为骨桥蛋白源的用途 |
| CN113567573B (zh) * | 2021-07-09 | 2023-06-02 | 黑龙江飞鹤乳业有限公司 | 骨桥蛋白的分离方法和分析方法 |
| GB202110114D0 (en) | 2021-07-14 | 2021-08-25 | Dentherapy Ltd | Oral care compositions for use in treaatment |
| EP4587455A1 (en) | 2022-09-16 | 2025-07-23 | Univerza V Ljubljani | Isolation of osteopontin and glycomacropeptide from whey |
| WO2025008636A1 (en) | 2023-07-06 | 2025-01-09 | Dentherapy Ltd | Oral care compositions for use in the treatment of dental health conditions |
| CN117837766A (zh) * | 2023-12-27 | 2024-04-09 | 美维仕(北京)健康管理有限公司 | 营养组合物及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998014071A1 (en) * | 1996-10-01 | 1998-04-09 | John Stephen Ayers | Process for isolating glycomacropeptide from dairy products with a phenylalanine impurity of 0.5 %w/w |
| AU748002B2 (en) | 1997-12-31 | 2002-05-30 | Depuy Orthopaedics, Inc. | Osteopontin-based compositions for enhancing bone repair |
| ATE321066T1 (de) * | 1998-05-06 | 2006-04-15 | Genentech Inc | Anti-her2 antikörperzusammensetzung |
| CA2393270A1 (en) * | 1999-12-08 | 2001-06-14 | Massey University | Process for separation of whey proteins using a novel anion exchanger |
| US7259243B2 (en) * | 2000-01-07 | 2007-08-21 | Arla Foods Amba | Process for isolation of osteopontin from milk |
| NZ507335A (en) | 2000-10-05 | 2004-10-29 | New Zealand Dairy Board | Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP |
-
2012
- 2012-03-05 EP EP12707103.3A patent/EP2681231B1/en active Active
- 2012-03-05 MX MX2013010019A patent/MX2013010019A/es active IP Right Grant
- 2012-03-05 DK DK12707103.3T patent/DK2681231T3/en active
- 2012-03-05 PL PL12707103T patent/PL2681231T3/pl unknown
- 2012-03-05 ES ES12707103.3T patent/ES2565380T3/es active Active
- 2012-03-05 MX MX2013010017A patent/MX2013010017A/es active IP Right Grant
- 2012-03-05 DK DK12706623.1T patent/DK2681230T3/en active
- 2012-03-05 KR KR1020137026174A patent/KR101940829B1/ko active Active
- 2012-03-05 JP JP2013555901A patent/JP6012053B2/ja active Active
- 2012-03-05 AU AU2012222312A patent/AU2012222312B2/en active Active
- 2012-03-05 PL PL12706623T patent/PL2681230T3/pl unknown
- 2012-03-05 CA CA2828746A patent/CA2828746C/en active Active
- 2012-03-05 BR BR112013022252-2A patent/BR112013022252B1/pt active IP Right Grant
- 2012-03-05 EP EP12706623.1A patent/EP2681230B1/en active Active
- 2012-03-05 AU AU2012222313A patent/AU2012222313B2/en active Active
- 2012-03-05 WO PCT/EP2012/053749 patent/WO2012117120A1/en not_active Ceased
- 2012-03-05 CN CN201280015375.4A patent/CN103476787B/zh active Active
- 2012-03-05 JP JP2013555900A patent/JP5967665B2/ja active Active
- 2012-03-05 CA CA2828669A patent/CA2828669C/en active Active
- 2012-03-05 WO PCT/EP2012/053748 patent/WO2012117119A1/en not_active Ceased
- 2012-03-05 EA EA201391204A patent/EA023615B1/ru not_active IP Right Cessation
- 2012-03-05 US US14/002,614 patent/US9181325B2/en active Active
- 2012-03-05 US US14/002,578 patent/US9181316B2/en active Active
- 2012-03-05 BR BR112013022251-4A patent/BR112013022251B1/pt active IP Right Grant
- 2012-03-05 CN CN201510434329.3A patent/CN105085649B/zh active Active
- 2012-03-05 EA EA201391203A patent/EA023367B1/ru not_active IP Right Cessation
- 2012-03-05 KR KR1020137026175A patent/KR101940830B1/ko active Active
- 2012-03-05 ES ES12706623.1T patent/ES2565379T3/es active Active
- 2012-03-05 CN CN201280015495.4A patent/CN103492408B/zh active Active
- 2012-03-06 AR ARP120100714A patent/AR088719A1/es active IP Right Grant
- 2012-03-06 AR ARP120100713A patent/AR085620A1/es active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2013010019A (es) | Metodo para aislamiento de osteopontina utilizando alimentos concentrados. | |
| MX2014002053A (es) | Anticuerpos anti -mcsp y metodos de uso. | |
| MX2014002253A (es) | Metodo para preparar una composicion que comprende anticuerpos altamente concentrados por ultrafiltracion. | |
| MX2013011479A (es) | Anticuerpos anti-fgfr4 y metodos de uso. | |
| PH12014500841B1 (en) | ANTI-HtrA1 ANTIBODIES AND METHODS OF USE | |
| PH12014501427B1 (en) | Anti-phf-tau antibodies and their uses | |
| MX364908B (es) | Purificación de proteínas usando amortiguador bis-tris. | |
| UA116088C2 (uk) | Спосіб та композиція для боротьби з бур'янами (варіанти) | |
| MX354267B (es) | Nucléosidos, nucleótidos, y ácidos nucleicos modificados, y usos de los mismos. | |
| WO2012106735A3 (en) | Plasma-assisted skin treatment | |
| EP4375371A3 (en) | Methods for the manufacture of proteolytically processed polypeptides | |
| MX2013009362A (es) | Anticuerpo contra el csf-1r. | |
| SG195196A1 (en) | Dual targeting | |
| HK1221472A1 (zh) | 用於增加蛋白质的焦谷氨酸形成的方法 | |
| EA201491286A1 (ru) | Способ лечения потери костной массы альвеолярного отростка посредством применения антител к склеростину | |
| EP3202886A4 (en) | Cultured algae water concentration system, method for operating cultured algae water concentration system, and method for concentrating algae water containing cultured algae | |
| IN2014CN04050A (enExample) | ||
| MX2013013685A (es) | Metodo para tratar articulos con dioxido de carbono. | |
| MY168394A (en) | Apparatus and Method of Using the Same | |
| IN2014CN03197A (enExample) | ||
| CA2933200C (en) | RSV-SPECIFIC ANTIBODIES AND THEIR FUNCTIONAL PARTS | |
| SG11201605882TA (en) | Method for culturing lactic acid bacteria at high concentration | |
| MY186606A (en) | Polynucleotide sequences from rhodosporidium and rhodotorula and use thereof | |
| MY178471A (en) | Microorganisms for producing diamine and process for producing diamine using them | |
| MY181148A (en) | Microorganisms for producing diamine and process for producing diamine using them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |